Patents by Inventor Bruce Tsan-Tang Liang

Bruce Tsan-Tang Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the detection and monitoring of congestive heart failure
    Patent number: 7998690
    Abstract: Disclosed herein are methods of detecting and/or prognosing congestive heart failure by detecting a proteolytic fragment of caspase-3 such as the p17 fragment or the p12 fragment. The congestive heart failure can be of any etiology, such as systolic or diastolic heart failure, ischemic or non-ischemic cardiomyopathy.
    Type: Grant
    Filed: April 22, 2010
    Date of Patent: August 16, 2011
    Assignee: The University of Connecticut
    Inventors: Bruce Tsan-Tang Liang, W. David Hager
  • Methods to protect skeletal muscle against injury
    Patent number: 7867983
    Abstract: Disclosed herein are compositions and methods for the treatment of skeletal muscle and/or the protection of skeletal muscle against injury. The adenosine A3 receptor has been identified as a new therapeutic target for the treatment of skeletal muscle. Adenosine A3 receptor agonists are used treat subjects with skeletal muscle ischemia and reperfusion (I/R) injuries, individuals with skeletal muscle disorders, and individuals suffering from skeletal muscle injury resulting from physical exertion.
    Type: Grant
    Filed: March 25, 2008
    Date of Patent: January 11, 2011
    Assignees: The University of Connecticut, The United States of America as represented by the Secretary of the Army
    Inventors: Bruce Tsan-Tang Liang, Edward John Zambraski
  • Methods for the Detection and Monitoring of Congestive Heart Failure
    Publication number: 20100203566
    Abstract: Disclosed herein are methods of detecting and/or prognosing congestive heart failure by detecting a proteolytic fragment of caspase-3 such as the p17 fragment or the p12 fragment. The congestive heart failure can be of any etiology, such as systolic or diastolic heart failure, ischemic or non-ischemic cardiomyopathy.
    Type: Application
    Filed: April 22, 2010
    Publication date: August 12, 2010
    Applicant: THE UNIVERSITY OF CONNECTICUT
    Inventors: Bruce Tsan-Tang Liang, W. David Hager
  • Methods for the detection and monitoring of congestive heart failure
    Patent number: 7745150
    Abstract: Disclosed herein are methods of detecting and/or prognosing congestive heart failure by detecting a proteolytic fragment of caspase-3 such as the p17 fragment or the p12 fragment. The congestive heart failure can be of any etiology, such as systolic or diastolic heart failure, ischemic or non-ischemic cardiomyopathy.
    Type: Grant
    Filed: March 9, 2009
    Date of Patent: June 29, 2010
    Assignee: The University of Connecticut
    Inventors: Bruce Tsan-Tang Liang, W. David Hager
  • Methods for the Detection and Monitoring of Congestive Heart Failure
    Publication number: 20090226937
    Abstract: Disclosed herein are methods of detecting and/or prognosing congestive heart failure by detecting a proteolytic fragment of caspase-3 such as the p17 fragment or the p12 fragment. The congestive heart failure can be of any etiology, such as systolic or diastolic heart failure, ischemic or non-ischemic cardiomyopathy.
    Type: Application
    Filed: March 9, 2009
    Publication date: September 10, 2009
    Applicant: THE UNIVERSITY OF CONNECTICUT
    Inventors: Bruce Tsan-Tang Liang, W. David Hager
  • Methods to Protect Skeletal Muscle Against Injury
    Publication number: 20080312180
    Abstract: Disclosed herein are compositions and methods for the treatment of skeletal muscle and/or the protection of skeletal muscle against injury. The adenosine A3 receptor has been identified as a new therapeutic target for the treatment of skeletal muscle. Adenosine A3 receptor agonists are used treat subjects with skeletal muscle ischemia and reperfusion (I/R) injuries, individuals with skeletal muscle disorders, and individuals suffering from skeletal muscle injury resulting from physical exertion.
    Type: Application
    Filed: March 25, 2008
    Publication date: December 18, 2008
    Applicants: Institute of Enviromental Medicine
    Inventors: Bruce Tsan-Tang Liang, Edward John Zambraski